Genohco제노코

Genohco is loss-making on a trailing basis, with revenue roughly flat and shares down about 31% over the past year.

Genohco, a Korean aerospace and defense electronics maker, reported trailing twelve-month revenue of about ₩57.6B but an operating loss of about ₩1.7B and a net loss of about ₩1.1B through H1 2026. Its operating losses have persisted since 2024 after profitable years in 2021 to 2023, and its cash of about ₩34.5B is held against negative free cash flow of about ₩6.7B. The data does not include the reason for the share price decline.

What stands out

• Revenue has grown modestly: ₩59.6B in 2025, up 4.9%, after ₩56.8B in 2024, but operating margin has been negative since 2024 (−3.5% in 2025).
• Operating income fell from a ₩4.3B profit in 2021 to a ₩2.1B loss in 2025, and net income was negative in both 2024 and 2025.
• Cash of about ₩34.5B is listed with no borrowings reported, and liabilities are 38.6% of equity.
• Shares closed at ₩10,970, down 20% over three months and 31.1% over one year, well above the 52-week low of ₩9,710 and far below the high of ₩36,900.
• Recent filings include an extraordinary shareholders' meeting held in late September 2026 and an amended major sales or supply contract filed in August 2026; the data includes no news headlines to explain them.

What to watch

• Next quarterly and annual results, to see whether operating losses narrow from the H1 2026 trailing figures.
• Negative free cash flow of about ₩6.7B against ₩34.5B cash, and whether the company needs outside funding; the data shows no borrowings but gives no forward plan.
• Details of the extraordinary shareholders' meeting results and the amended supply contract, which the data does not describe.